Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valeria Famiglini

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Journal of Medicinal Chemistry|June 21, 2012
New nitrogen containing substituents at the indole-2-carboxamide yield high potent and broad spectrum indolylarylsulfone HIV-1 non-nucleoside reverse transcriptase inhibitorsGiuseppe La Regina, Antonio Coluccia, Andrea Brancale, et al.
Journal of Medicinal Chemistry|December 4, 2013
Design, synthesis, and biological evaluation of 1-phenylpyrazolo[3,4-e]pyrrolo[3,4-g]indolizine-4,6(1H,5H)-diones as new glycogen synthase kinase-3β inhibitorsValeria La Pietra, Giuseppe La Regina, Antonio Coluccia, et al.
Journal of Medicinal Chemistry|October 27, 2015
Discovery of 1,1'-Biphenyl-4-sulfonamides as a New Class of Potent and Selective Carbonic Anhydrase XIV InhibitorsGiuseppe La Regina, Antonio Coluccia, Valeria Famiglini, et al.
Journal of Medicinal Chemistry|June 20, 2017
Chiral Indolylarylsulfone Non-Nucleoside Reverse Transcriptase Inhibitors as New Potent and Broad Spectrum Anti-HIV-1 AgentsValeria Famiglini, Giuseppe La Regina, Antonio Coluccia, et al.
Journal of Medicinal Chemistry|November 25, 2014
Indolylarylsulfones carrying a heterocyclic tail as very potent and broad spectrum HIV-1 non-nucleoside reverse transcriptase inhibitorsValeria Famiglini, Giuseppe La Regina, Antonio Coluccia, et al.
European Journal of Medicinal Chemistry|December 9, 2014
New 1-phenyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides inhibit hepatitis C virus replication via suppression of cyclooxygenase-2Dinesh Manvar, Sveva Pelliccia, Giuseppe La Regina, et al.
European Journal of Medicinal Chemistry|May 7, 2018
New 6- and 7-heterocyclyl-1H-indole derivatives as potent tubulin assembly and cancer cell growth inhibitorsGiuseppe La Regina, Ruoli Bai, Antonio Coluccia, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|January 19, 2017
Exploring the first Rimonabant analog-opioid peptide hybrid compound, as bivalent ligand for CB1 and opioid receptorsAdriano Mollica, Sveva Pelliccia, Valeria Famiglini, et al.
Oncogene|March 20, 2018
β-catenin knockdown promotes NHERF1-mediated survival of colorectal cancer cells: implications for a double-targeted therapyConcetta Saponaro, Sara Sergio, Antonio Coluccia, et al.
ACS Medicinal Chemistry Letters|May 20, 2017
3-Aroyl-1,4-diarylpyrroles Inhibit Chronic Myeloid Leukemia Cell Growth through an Interaction with TubulinGiuseppe La Regina, Ruoli Bai, Antonio Coluccia, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of Medicinal Chemistry|June 21, 2012
New nitrogen containing substituents at the indole-2-carboxamide yield high potent and broad spectrum indolylarylsulfone HIV-1 non-nucleoside reverse transcriptase inhibitorsGiuseppe La Regina, Antonio Coluccia, Andrea Brancale, et al.
Journal of Medicinal Chemistry|December 4, 2013
Design, synthesis, and biological evaluation of 1-phenylpyrazolo[3,4-e]pyrrolo[3,4-g]indolizine-4,6(1H,5H)-diones as new glycogen synthase kinase-3β inhibitorsValeria La Pietra, Giuseppe La Regina, Antonio Coluccia, et al.
Journal of Medicinal Chemistry|October 27, 2015
Discovery of 1,1'-Biphenyl-4-sulfonamides as a New Class of Potent and Selective Carbonic Anhydrase XIV InhibitorsGiuseppe La Regina, Antonio Coluccia, Valeria Famiglini, et al.
Journal of Medicinal Chemistry|June 20, 2017
Chiral Indolylarylsulfone Non-Nucleoside Reverse Transcriptase Inhibitors as New Potent and Broad Spectrum Anti-HIV-1 AgentsValeria Famiglini, Giuseppe La Regina, Antonio Coluccia, et al.
Journal of Medicinal Chemistry|November 25, 2014
Indolylarylsulfones carrying a heterocyclic tail as very potent and broad spectrum HIV-1 non-nucleoside reverse transcriptase inhibitorsValeria Famiglini, Giuseppe La Regina, Antonio Coluccia, et al.
European Journal of Medicinal Chemistry|December 9, 2014
New 1-phenyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides inhibit hepatitis C virus replication via suppression of cyclooxygenase-2Dinesh Manvar, Sveva Pelliccia, Giuseppe La Regina, et al.
European Journal of Medicinal Chemistry|May 7, 2018
New 6- and 7-heterocyclyl-1H-indole derivatives as potent tubulin assembly and cancer cell growth inhibitorsGiuseppe La Regina, Ruoli Bai, Antonio Coluccia, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|January 19, 2017
Exploring the first Rimonabant analog-opioid peptide hybrid compound, as bivalent ligand for CB1 and opioid receptorsAdriano Mollica, Sveva Pelliccia, Valeria Famiglini, et al.
Oncogene|March 20, 2018
β-catenin knockdown promotes NHERF1-mediated survival of colorectal cancer cells: implications for a double-targeted therapyConcetta Saponaro, Sara Sergio, Antonio Coluccia, et al.
ACS Medicinal Chemistry Letters|May 20, 2017
3-Aroyl-1,4-diarylpyrroles Inhibit Chronic Myeloid Leukemia Cell Growth through an Interaction with TubulinGiuseppe La Regina, Ruoli Bai, Antonio Coluccia, et al.
Pageof 3